Central African Republic - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Central African Republic Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases jumped by 19.9% year on year. At 99 Cases in 2019, the country was number 138 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Central African Republic is overtaken by Djibouti, which was number 137 with 100 Cases and is followed by Liberia with 98 Cases. India ranked the highest with 66,255 Cases in 2019, a growth of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 99.00 |
| 2018 | 58.00 |
| 2017 | 93.00 |
| 2016 | 57.00 |
| 2015 | 62.00 |
How does Central African Republic rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 136 |
#136
Rwanda
|
101 | 2019 | +4.1 % | +4.3 % | View data | |
| 138 |
#138
Central African Republic
|
99 | 2019 | +70.7 % | +19.9 % | View data | |
| 139 |
#139
Liberia
|
98 | 2019 | +8.9 % | NA | View data | |